ROLE OF RED COMPLEX PATHOGENS IN THE DEVELOPMENT OF CARDIOVASCULAR DISEASES
DOI:
https://doi.org/10.61841/8ppe6r59Keywords:
Cardiovascular diseases; red complex pathogens; atherosclerosis; periodontal diseases; gingivitisAbstract
The pathophysiology of cardiovascular disease (CVD) includes inflammation which ultimately leads to the development of atherosclerosis and thrombosis. Increasing evidence supports oral infections and in particular the common periodontal diseases, to be associated with CVD development. Periodontal infections are common worldwide and in moderate to mild form in about 35% population according to the World Health Organization. The aim of this study is to present a brief review of recent literature available on the association of red complex pathogens in development of CVD. A brief description of oral bacteria, periodontal diseases, atherosclerosis, underlying pathophysiology has been included. There is growing evidence on the association of periodontal diseases and CVD as given by epidemiological studies. The relationship between periodontal red complex pathogens and CVD deserves further research because of its consequences for public health.
Downloads
References
1. Leishman SJ, Do HL, Ford PJ. Cardiovascular disease and the role of oral bacteria. J Oral Microbiol 2010;2.
https://doi.org/10.3402/jom.v2i0.5781.
2. Grossi SG, Genco RJ, Machtet EE, Ho AW, Koch G, Dunford R, et al. Assessment of Risk for Periodontal Disease.
II. Risk Indicators for Alveolar Bone Loss. Journal of Periodontology 1995;66:23–9.
https://doi.org/10.1902/jop.1995.66.1.23.
3. Inaba H, Amano A. Roles of Oral Bacteria in Cardiovascular Diseases — From Molecular Mechanisms to Clinical
Cases: Implication of Periodontal Diseases in Development of Systemic Diseases. Journal of Pharmacological
Sciences 2010;113:103–9. https://doi.org/10.1254/jphs.09r23fm.
4. Madianos PN, Bobetsis GA, Kinane DF. Is periodontitis associated with an increased risk of coronary heart disease
and preterm and/or low birth weight births? J Clin Periodontol 2002;29 Suppl 3:22–36; discussion 37–8.
https://doi.org/10.1034/j.1600-051x.29.s3.2.x.
5. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease:
A narrative review and clinical perspective of prospective data. Hepatology 2010;52:1156–61.
https://doi.org/10.1002/hep.23789.
6. Chen Z-Y, Chiang C-H, Huang C-C, Chung C-M, Chan W-L, Huang P-H, et al. The association of tooth scaling
and decreased cardiovascular disease: a nationwide population-based study. Am J Med 2012;125:568–75.
https://doi.org/10.1016/j.amjmed.2011.10.034.
7. Shahana RY, Muralidharan NP. Efficacy of mouth rinse in maintaining oral health of patients attending orthodontic
clinics. Research Journal of Pharmacy and Technology 2016;9:1991. https://doi.org/10.5958/0974-
360x.2016.00406.6.
8. Ashwin KS, Muralidharan NP. Vancomycin-resistant enterococcus (VRE) vs Methicillin-resistant Staphylococcus
Aureus (MRSA). Indian Journal of Medical Microbiology 2015;33:166. https://doi.org/10.4103/0255-0857.150976.
9. Cotti E, Dessì C, Piras A, Mercuro G. Can a chronic dental infection be considered a cause of cardiovascular
disease? A review of the literature. Int J Cardiol 2011;148:4–10. https://doi.org/10.1016/j.ijcard.2010.08.011.
10. Pratha AA, Ashwatha Pratha A, Geetha RV. Awareness on Hepatitis-B vaccination among dental students-A
Questionnaire Survey. Research Journal of Pharmacy and Technology 2017;10:1360. https://doi.org/10.5958/0974-
360x.2017.00240.2.
11. Mysak J, Podzimek S, Sommerova P, Lyuya-Mi Y, Bartova J, Janatova T, et al. Porphyromonas gingivalis: major
periodontopathic pathogen overview. J Immunol Res 2014;2014:476068. https://doi.org/10.1155/2014/476068.
12. Marickar RF, Geetha RV, Neelakantan P. Efficacy of Contemporary and Novel Intracanal Medicaments
againstEnterococcus Faecalis. Journal of Clinical Pediatric Dentistry 2014;39:47–50.
https://doi.org/10.17796/jcpd.39.1.wmw9768314h56666.
13. Girija ASS, Smiline Girija AS, Vijayashree Priyadharsini J, Paramasivam A. Plasmid-encoded resistance to
trimethoprim/sulfamethoxazole mediated by dfrA1, dfrA5, sul1 and sul2 among Acinetobacter baumannii isolated
from urine samples of patients with severe urinary tract infection. Journal of Global Antimicrobial Resistance
2019;17:145–6. https://doi.org/10.1016/j.jgar.2019.04.001.
14. Thakare KS, Deo V, Bhongade ML. Evaluation of the C-reactive protein serum levels in periodontitis patients with
or without atherosclerosis. Indian J Dent Res 2010;21:326–9. https://doi.org/10.4103/0970-9290.70787.
15. Selvakumar R, Np M. Comparison In Benefits Of Herbal Mouthwashes With Chlorhexidine Mouthwash: A
Review. Asian Journal of Pharmaceutical and Clinical Research 2017;10:3.
https://doi.org/10.22159/ajpcr.2017.v10i2.13304.
16. Vaishali M, Geetha RV. Antibacterial activity of Orange peel oil on Streptococcus mutans and Enterococcus-An Invitro study. Research Journal of Pharmacy and Technology 2018;11:513. https://doi.org/10.5958/0974-
360x.2018.00094.x.
17. Carrouel F, Viennot S, Santamaria J, Veber P, Bourgeois D. Quantitative Molecular Detection of 19 Major
Pathogens in the Interdental Biofilm of Periodontally Healthy Young Adults. Frontiers in Microbiology 2016;7.
https://doi.org/10.3389/fmicb.2016.00840.
18. Shahzan MS, Sohaib Shahzan M, Smiline Girija AS, Vijayashree Priyadharsini J. A computational study targeting
the mutated L321F of ERG11 gene in C. albicans, associated with fluconazole resistance with bioactive compounds
from Acacia nilotica. Journal de Mycologie Médicale 2019;29:303–9.
https://doi.org/10.1016/j.mycmed.2019.100899.
19. M MA, Geetha RV, Thangavelu L. Evaluation oEvaluation of anti-inflammatory action of Laurus nobilis-an in
vitro studyf anti-inflammatory action of Laurus nobilis-an in vitro study. International Journal of Research in
Pharmaceutical Sciences 2019;10:1209–13. https://doi.org/10.26452/ijrps.v10i2.408.
20. Kadowaki T, Nakayama K, Yoshimura F, Okamoto K, Abe N, Yamamoto K. Arg-gingipain acts as a major
processing enzyme for various cell surface proteins in Porphyromonas gingivalis. J Biol Chem 1998;273:29072–6.
https://doi.org/10.1074/jbc.273.44.29072.
21. Priyadharsini JV, Vijayashree Priyadharsini J, Smiline Girija AS, Paramasivam A. In silico analysis of virulence
genes in an emerging dental pathogen A. baumannii and related species. Archives of Oral Biology 2018;94:93–8.
https://doi.org/10.1016/j.archoralbio.2018.07.001.
22. Hujoel PP, Drangsholt MT, Spiekerman C, DeRouen TA. Periodontal disease and risk of coronary heart disease.
JAMA 2001; 285:40–1.
23. Wu T, Trevisan M, Genco RJ, Falkner KL, Dorn JP, Sempos CT. Examination of the Relation between Periodontal
Health Status and Cardiovascular Risk Factors: Serum Total and High Density Lipoprotein Cholesterol, C-reactive
Protein, and Plasma Fibrinogen. American Journal of Epidemiology 2000;151:273–82.
https://doi.org/10.1093/oxfordjournals.aje.a010203.
24. Seinost G, Wimmer G, Skerget M, Thaller E, Brodmann M, Gasser R, et al. Periodontal treatment improves
endothelial dysfunction in patients with severe periodontitis. Am Heart J 2005;149:1050–4.
https://doi.org/10.1016/j.ahj.2004.09.059.
25. Bullon P, Cordero MD, Quiles JL, Morillo JM, del Carmen Ramirez-Tortosa M, Battino M. Mitochondrial
dysfunction promoted by Porphyromonas gingivalis lipopolysaccharide as a possible link between cardiovascular
disease and periodontitis. Free Radic Biol Med 2011;50:1336–43.
https://doi.org/10.1016/j.freeradbiomed.2011.02.018.
26. Persson GR, Rutger Persson G. Chronic periodontitis, a significant relationship with acute myocardial infarction.
European Heart Journal 2003;24:2108–15. https://doi.org/10.1016/j.ehj.2003.10.007.
27. Smiline ASG, Vijayashree JP, Paramasivam A. Molecular characterization of plasmid-encoded blaTEM, blaSHV
and blaCTX-M among extended spectrum β-lactamases [ESBLs] producing Acinetobacter baumannii. British
Journal of Biomedical Science 2018;75:200–2. https://doi.org/10.1080/09674845.2018.1492207.
28. Linden GJ, Herzberg MC, on behalf of working group 4 of the joint EFP/AAP workshop. Periodontitis and
systemic diseases: a record of discussions of working group 4 of the Joint EFP/AAP Workshop on Periodontitis and
Systemic Diseases. Journal of Periodontology 2013;84:S20–3. https://doi.org/10.1902/jop.2013.1340020.
29. Buhlin K, Gustafsson A, Andersson K, Hakansson J, Klinge B. Validity and limitations of self-reported periodontal
health. Community Dentistry and Oral Epidemiology 2002;30:431–7. https://doi.org/10.1034/j.1600-
0528.2002.00014.x.
30. Kozarov E. Bacterial invasion of vascular cell types: vascular infectology and atherogenesis. Future Cardiology
2012;8:123–38. https://doi.org/10.2217/fca.11.75.
31. Girija SAS, Jayaseelan VP, Arumugam P. Prevalence of VIM- and GIM-producing Acinetobacter baumannii from
patients with severe urinary tract infection. Acta Microbiologica et Immunologica Hungarica 2018;65:539–50.
https://doi.org/10.1556/030.65.2018.038.
32. Paramasivam A, Vijayashree Priyadharsini J, Raghunandhakumar S. N6-adenosine methylation (m6A): a
promising new molecular target in hypertension and cardiovascular diseases. Hypertens Res 2020;43:153–4.
https://doi.org/10.1038/s41440-019-0338-z.
33. Beck JD, Couper DJ, Falkner KL, Graham SP, Grossi SG, Gunsolley JC, et al. The Periodontitis and Vascular
Events (PAVE) pilot study: adverse events. J Periodontol 2008;79:90–6. https://doi.org/10.1902/jop.2008.070223.
34. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. Identification of periodontal pathogens in atheromatous
plaques. J Periodontol 2000;71:1554–60. https://doi.org/10.1902/jop.2000.71.10.1554.
35. SmilineGirija AS, VijayashreePriyadharsini J, Paramasivam Arumugam. CLSI based antibiogram profile and the
detection of MDR and XDR strains of Acinetobacter baumannii isolated from urine samples. Medical Journal of the
Islamic Republic of Iran. 2019; 33(3); 11- 16.https://doi.org/10.34171/mjiri.33.3.
36. Reyes L, Herrera D, Kozarov E, Roldá S, Progulske-Fox A. Periodontal bacterial invasion and infection:
contribution to atherosclerotic pathology. J Periodontol 2013;84:S30–50. https://doi.org/10.1902/jop.2013.1340012.
37. Schenkein HA, Loos BG. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases.
Journal of Clinical Periodontology 2013;40:S51–69. https://doi.org/10.1111/jcpe.12060.
38. Meurman JH, Janket S-J, Qvarnström M, Nuutinen P. Dental infections and serum inflammatory markers in
patients with and without severe heart disease. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and
Endodontology 2003;96:695–700. https://doi.org/10.1016/j.tripleo.2003.08.017.
39. Linden GJ, Lyons A, Scannapieco FA. Periodontal systemic associations: review of the evidence. Journal of
Periodontology 2013;84:S8–19. https://doi.org/10.1902/jop.2013.1340010
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
